10x Genomics Other Non-Current Liabilities 2018-2024 | TXG

10x Genomics other non-current liabilities from 2018 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
10x Genomics Annual Other Non-Current Liabilities
(Millions of US $)
2024 $5
2023 $4
2022 $3
2021 $14
2020 $15
2019 $87
2018 $39
2017 $0
10x Genomics Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-12-31 $5
2024-09-30 $5
2024-06-30 $5
2024-03-31 $5
2023-12-31 $4
2023-09-30 $10
2023-06-30 $8
2023-03-31 $7
2022-12-31 $3
2022-09-30 $6
2022-06-30 $9
2022-03-31 $9
2021-12-31 $14
2021-09-30 $14
2021-06-30 $14
2021-03-31 $15
2020-12-31 $15
2020-09-30 $15
2020-06-30 $14
2020-03-31 $86
2019-12-31 $87
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $39
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.053B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.557B 53.26
Tempus AI (TEM) United States $9.312B 0.00
Hims & Hers Health (HIMS) United States $9.304B 97.39
Inspire Medical Systems (INSP) United States $4.724B 73.15
IRhythm Technologies (IRTC) United States $4.334B 0.00
Privia Health (PRVA) United States $2.788B 208.91
Enovis (ENOV) United States $1.951B 12.07
Schrodinger (SDGR) United States $1.898B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Phreesia (PHR) United States $1.483B 0.00
Omnicell (OMCL) United States $1.428B 30.80
Azenta (AZTA) United States $1.197B 55.74
Fulgent Genetics (FLGT) United States $0.595B 0.00
Butterfly Network (BFLY) United States $0.539B 0.00
Talkspace (TALK) United States $0.527B 313.00
Veradigm (MDRX) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.437B 0.00
TruBridge (TBRG) United States $0.393B 0.00
Claritev (CTEV) United States $0.346B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.221B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
Pulmonx (LUNG) United States $0.144B 0.00
American Well (AMWL) United States $0.114B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.083B 0.00
CareCloud (CCLD) United States $0.074B 3.18
111 (YI) China $0.070B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00